110 related articles for article (PubMed ID: 9737386)
1. Experience with the Vero cell line.
Montagnon BJ; Vincent-Falquet JC
Dev Biol Stand; 1998; 93():119-23. PubMed ID: 9737386
[TBL] [Abstract][Full Text] [Related]
2. Experience with vero cells at Pasteur Mérieux Connaught.
Montagnon BJ; Vincent-Falquet JC; Saluzzo JF
Dev Biol Stand; 1999; 98():137-40; discussion 167. PubMed ID: 10494966
[TBL] [Abstract][Full Text] [Related]
3. Polio and rabies vaccines produced in continuous cell lines: a reality for Vero cell line.
Montagnon BJ
Dev Biol Stand; 1989; 70():27-47. PubMed ID: 2759353
[TBL] [Abstract][Full Text] [Related]
4. Systematically experimental investigation on carcinogenesis or tumorigenicity of VERO cell lines of different karyotypes in nude mice in vivo used for viral vaccine manufacture.
Zhang DL; Ji L; Li LJ; Huang GS
Yi Chuan Xue Bao; 2004 Jul; 31(7):647-60. PubMed ID: 15473315
[TBL] [Abstract][Full Text] [Related]
5. Qualification of working cell banks for the Vero cell line to produce licensed human vaccines.
Vincent-Falquet JC; Peyron L; Souvras M; Moulin JC; Tektoff J; Patet J
Dev Biol Stand; 1989; 70():153-6. PubMed ID: 2759347
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): a randomized, double-blind trial with purified Vero-cell rabies vaccine (PVRV).
Lang J; Cetre JC; Picot N; Lanta M; Briantais P; Vital S; Le Mener V; Lutsch C; Rotivel Y
Biologicals; 1998 Dec; 26(4):299-308. PubMed ID: 10403033
[TBL] [Abstract][Full Text] [Related]
7. Growth and immunogenicity of influenza viruses cultivated in Vero or MDCK cells and in embryonated chicken eggs.
Govorkova EA; Kodihalli S; Alymova IV; Fanget B; Webster RG
Dev Biol Stand; 1999; 98():39-51; discussion 73-4. PubMed ID: 10494958
[TBL] [Abstract][Full Text] [Related]
8. A rabies vaccine produced in a non-tumorigenic rabbit cell line.
Sureau P; Perrin P; Horaud F
Dev Biol Stand; 1985; 60():133-9. PubMed ID: 4043531
[TBL] [Abstract][Full Text] [Related]
9. Suspension-Vero cell cultures as a platform for viral vaccine production.
Paillet C; Forno G; Kratje R; Etcheverrigaray M
Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and safety of a new Vero cell rabies vaccine produced using serum-free medium.
Costa WA; Cunha RS; Bolzan VL; Silva Ade C; Caporale GM; Chaves LB; Oselka GW; Junqueira DA; Panacho MR; Dias RA; Takaoka NY
Vaccine; 2007 Nov; 25(48):8140-5. PubMed ID: 18029066
[TBL] [Abstract][Full Text] [Related]
11. A microcarrier cell culture process for propagating rabies virus in Vero cells grown in a stirred bioreactor under fully animal component free conditions.
Rourou S; van der Ark A; van der Velden T; Kallel H
Vaccine; 2007 May; 25(19):3879-89. PubMed ID: 17307281
[TBL] [Abstract][Full Text] [Related]
12. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
Barrett PN; Mundt W; Kistner O; Howard MK
Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
[TBL] [Abstract][Full Text] [Related]
13. Development of a Vero cell-derived influenza whole virus vaccine.
Kistner O; Barrett PN; Mundt W; Reiter M; Schober-Bendixen S; Eder G; Dorner F
Dev Biol Stand; 1999; 98():101-10; discussion 111. PubMed ID: 10494963
[TBL] [Abstract][Full Text] [Related]
14. Establishment of an immortal turkey turbinate cell line suitable for avian metapneumovirus propagation.
Kong BW; Foster LK; Foster DN
Virus Res; 2007 Jul; 127(1):106-15. PubMed ID: 17482704
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of influenza virus replication in Vero and MDCK cell lines.
Youil R; Su Q; Toner TJ; Szymkowiak C; Kwan WS; Rubin B; Petrukhin L; Kiseleva I; Shaw AR; DiStefano D
J Virol Methods; 2004 Sep; 120(1):23-31. PubMed ID: 15234806
[TBL] [Abstract][Full Text] [Related]
16. Vero-cell rabies vaccine produced using serum-free medium.
Frazatti-Gallina NM; Mourão-Fuches RM; Paoli RL; Silva ML; Miyaki C; Valentini EJ; Raw I; Higashi HG
Vaccine; 2004 Dec; 23(4):511-7. PubMed ID: 15530700
[TBL] [Abstract][Full Text] [Related]
17. [Analyses of chromosomal karyotypes and cytogenetic variations of animal cell lines].
Zhang DL; Li LJ; Xia GT; He XY; Gao BX; Bai XH; Huang GS; Liu SG; Yan LF; Fang FD; Hu CL; Wang LJ; Jiang HH; Feng AM; Zhang GM; An SG; Ren YQ; Guo JM; Hu SX; Fan JX; Niu YL; Song ZJ; Li Y; Fan SJ
Yi Chuan Xue Bao; 2001; 28(4):327-44. PubMed ID: 11329875
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of Vero-cell infectious bursal disease vaccine in Pakistan.
Rasool MH; Hussain I
Vaccine; 2006 Apr; 24(15):2810-4. PubMed ID: 16490290
[TBL] [Abstract][Full Text] [Related]
19. Preventing rabies with the Verorab vaccine: 1985-2005 Twenty years of clinical experience.
Toovey S
Travel Med Infect Dis; 2007 Nov; 5(6):327-48. PubMed ID: 17983973
[TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
Haastrup E; Thierry-Carstensen B; Jensen AM; Stellfeld M; Heilmann C
Vaccine; 2004 Feb; 22(8):958-62. PubMed ID: 15161072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
